Add BrightSurf on Google Email

The Fontan circulation

The Fontan operation creates nonpulsatile pulmonary flow, leading to unique physiological consequences impacting the cardiovascular system and beyond. Innovative management strategies are needed to maintain quality of life and extend life expectancy in long-term survivors.

SourceCardiovascular Innovations and Applications·JournalCardiovascular Innovations and Applications·DateJun 10, 2018

High-risk, undertreated mystery heart attacks occurring more commonly in women

A University of Alberta study found that nearly six per cent of patients have a heart attack without any blockage in the arteries, with five per cent experiencing another heart attack or death within one year. Patients with MINOCA are twice as likely to be female and require more aggressive preventive treatment.

SourceUniversity of Alberta Faculty of Medicine & Dentistry·JournalInternational Journal of Cardiology·DateMay 29, 2018

Noise throws the heart out of rhythm

A recent study published in International Journal of Cardiology found that exposure to extreme noise annoyance increases the incidence of atrial fibrillation by up to 23%. Aircraft noise is identified as a major source of noise pollution, with 84% during the day and 69% at night. The study highlights the importance of measuring noise a...

SourceJohannes Gutenberg Universitaet Mainz·JournalInternational Journal of Cardiology·DateMay 3, 2018

SCAI updates consensus on length of stay for percutaneous coronary intervention

The Society for Cardiovascular Angiography and Interventions has updated its consensus guidelines to allow for flexibility in length of stay after percutaneous coronary intervention (PCI), prioritizing patient-centered care. The new guidelines assess readiness for discharge along three lines: procedural, patient, and programmatic factors.

SourceSociety for Cardiovascular Angiography and Interventions·JournalCatheterization and Cardiovascular Interventions·DateApr 25, 2018

Study: Medicaid expansion has no negative effect on cardiovascular procedural outcomes

A recent study published in the Journal of the American College of Cardiology found that Medicaid expansion in Michigan did not negatively impact patient outcomes for coronary artery disease procedures. The research used data from 7,558 CABG procedures and 45,183 PCI procedures performed at various hospitals across the state.

SourceMichigan Medicine - University of Michigan·JournalJournal of the American College of Cardiology·DateApr 9, 2018

Study supports biomarker assay for emergency department diagnosis of acute heart failure

A multi-institutional study validated age-based NT-proBNP diagnostic cutoff levels for diagnosing acute heart failure in patients seen at hospital emergency departments. The study found that a level below 300 strongly excluded a heart failure diagnosis, and the results were consistent across all groups of participants.

SourceMassachusetts General Hospital·JournalJournal of the American College of Cardiology·DateMar 22, 2018

Canakinumab reduces risk of cardiovascular events in populations with unmet clinical need

A new analysis found that canakinumab substantially reduced cardiovascular event rates among patients with diabetes and those with moderate to severe chronic kidney disease. The drug also showed benefits in reducing rates of major adverse cardiovascular events among high-risk atherosclerotic patients.

SourceBrigham and Women's Hospital·JournalJournal of the American College of Cardiology·DateMar 12, 2018

Beta blocker shows mixed results in protecting against chemo-induced heart damage

A study found that women with breast cancer who took the beta blocker carvedilol during chemotherapy had lower levels of a protein indicative of heart injury, but no difference in heart function. The study's lead author notes that further research is needed to confirm these findings and explore potential benefits for higher-risk patients.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateMar 11, 2018

When the doctor's away

Patients who receive treatment during periods when interventional cardiologists are away at academic conferences experience a substantial increase in survival rates compared to those treated on matched days. The improvement is primarily driven by a group of patients with a specific type of heart attack that does not require immediate s...

SourceHarvard Medical School·JournalJournal of the American Heart Association·DateMar 9, 2018

Renowned cardiologist says new blood pressure guidelines not good for all

A leading cardiologist has criticized the new hypertension guidelines, which he says could lead to more harm than benefit for certain individuals. The guidelines recommend intensive treatment for patients at a higher risk of cardiovascular disease, but Dr. Robert Phillips argues that those with lower risk may face unnecessary harm.

SourceHouston Methodist·JournalJournal of the American College of Cardiology·DateMar 7, 2018

Can your cardiac device be hacked?

Cybersecurity risks exist in cardiac devices due to software integration and wireless communications, according to the American College of Cardiology's Electrophysiology Council. The potential consequences include device malfunction, battery depletion, and interruptions in life-saving therapies.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateFeb 20, 2018

SNMMI and ASNC issue joint guidelines for quantification of myocardial blood flow using PET

The Society of Nuclear Medicine and Molecular Imaging and the American Society of Nuclear Cardiology have issued joint guidelines for the clinical quantification of myocardial blood flow using Positron Emission Tomography (PET). The guidelines provide a comprehensive framework for the measurement and interpretation of myocardial blood ...

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateFeb 13, 2018

Nearly 25 percent of chronic ischemic heart disease patients dead or hospitalized in 6 months

A European Society of Cardiology study found that nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead or hospitalised within six months. The study identified factors such as older age, history of peripheral revascularisation and chronic kidney disease as strongly associated with high risk.

SourceEuropean Society of Cardiology·JournalEuropean Journal of Preventive Cardiology·DateJan 17, 2018